A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Clinical trial NCT00529503 · TERMINATED

Trial details

NCT number: NCT00529503
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin

Start date: 2007-09-01
Primary completion: 2009-12-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.